Literature DB >> 21952643

Renal stone disease: a commentary on the nature and significance of Randall's plaque.

A P Evan1, R J Unwin, J C Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21952643      PMCID： PMC3701452          DOI： 10.1159/000330255

Source DB:  PubMed          Journal:  Nephron Physiol        ISSN： 1660-2137


× No keyword cloud information.
  19 in total

1.  Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease.

Authors:  Andrew P Evan; James E Lingeman; Elaine M Worcester; Sharon B Bledsoe; Andre J Sommer; James C Williams; Amy E Krambeck; Carrie L Philips; Fredric L Coe
Journal:  Kidney Int       Date:  2010-04-28       Impact factor: 10.612

2.  Plaque and deposits in nine human stone diseases.

Authors:  Fredric L Coe; Andrew P Evan; James E Lingeman; Elaine M Worcester
Journal:  Urol Res       Date:  2010-07-13

3.  Calcium oxalate nephrolithiasis, a free or fixed particle disease.

Authors:  D J Kok; S R Khan
Journal:  Kidney Int       Date:  1994-09       Impact factor: 10.612

4.  The expectation of free and fixed particles in urinary stone disease.

Authors:  B Finlayson; F Reid
Journal:  Invest Urol       Date:  1978-05

5.  Crystal-associated nephropathy in patients with brushite nephrolithiasis.

Authors:  Andrew P Evan; James E Lingeman; Fredric L Coe; Youzhi Shao; Joan H Parks; Sharon B Bledsoe; Carrie L Phillips; Stephen Bonsib; Elaine M Worcester; Andre J Sommer; Sam C Kim; William W Tinmouth; Marc Grynpas
Journal:  Kidney Int       Date:  2005-02       Impact factor: 10.612

Review 6.  Three pathways for human kidney stone formation.

Authors:  Fredric L Coe; Andrew P Evan; Elaine M Worcester; James E Lingeman
Journal:  Urol Res       Date:  2010-04-22

7.  Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy.

Authors:  Andrew P Evan; James E Lingeman; Fredric L Coe; Sharon B Bledsoe; Andre J Sommer; James C Williams; Amy E Krambeck; Elaine M Worcester
Journal:  Kidney Int       Date:  2009-08-26       Impact factor: 10.612

8.  Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients.

Authors:  A P Evan; S Bledsoe; E M Worcester; F L Coe; J E Lingeman; K J Bergsland
Journal:  Kidney Int       Date:  2007-09-26       Impact factor: 10.612

9.  Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones.

Authors:  Andrew E Evan; James E Lingeman; Fredric L Coe; Nicole L Miller; Sharon B Bledsoe; Andre J Sommer; James C Williams; Youzhi Shao; Elaine M Worcester
Journal:  Kidney Int       Date:  2008-04-30       Impact factor: 10.612

10.  Mechanism of formation of human calcium oxalate renal stones on Randall's plaque.

Authors:  Andrew P Evan; Fredric L Coe; James E Lingeman; Youzhi Shao; Andre J Sommer; Sharon B Bledsoe; Jennifer C Anderson; Elaine M Worcester
Journal:  Anat Rec (Hoboken)       Date:  2007-10       Impact factor: 2.064
View more
  9 in total

Review 1.  The role of calcium phosphate in the development of Randall's plaques.

Authors:  Hans-Göran Tiselius
Journal:  Urolithiasis       Date:  2013-08-21       Impact factor: 3.436

2.  How do stones form? Is unification of theories on stone formation possible?

Authors:  Victoria Y Bird; Saeed R Khan
Journal:  Arch Esp Urol       Date:  2017-01       Impact factor: 0.436

3.  Size-Dependent Cytotoxicity of Hydroxyapatite Crystals on Renal Epithelial Cells.

Authors:  Xin-Yuan Sun; Jia-Yun Chen; Chen-Ying Rao; Jian-Ming Ouyang
Journal:  Int J Nanomedicine       Date:  2020-07-15

4.  Distinguishing characteristics of idiopathic calcium oxalate kidney stone formers with low amounts of Randall's plaque.

Authors:  Xiangling Wang; Amy E Krambeck; James C Williams; Xiaojing Tang; Andrew D Rule; Fang Zhao; Eric Bergstralh; Zejfa Haskic; Samuel Edeh; David R Holmes; Loren P Herrera Hernandez; John C Lieske
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 8.237

5.  Increased renal papillary density in kidney stone formers detectable by CT scan is a potential marker of stone risk, but is unrelated to underlying hypercalciuria.

Authors:  Linda Shavit; Daniela Girfoglio; Alex Kirkham; Darrell Allen; Pietro Manuel Ferraro; Shabbir Moochhala; Robert Unwin
Journal:  Urolithiasis       Date:  2016-03-29       Impact factor: 3.436

Review 6.  New insights into the pathogenesis of renal calculi.

Authors:  Herman Singh Bagga; Thomas Chi; Joe Miller; Marshall L Stoller
Journal:  Urol Clin North Am       Date:  2012-10-23       Impact factor: 2.241

7.  Nephrocalcinosis (enamel renal syndrome) caused by autosomal recessive FAM20A mutations.

Authors:  Graciana Jaureguiberry; Muriel De la Dure-Molla; David Parry; Mickael Quentric; Nina Himmerkus; Toshiyasu Koike; James Poulter; Enriko Klootwijk; Steven L Robinette; Alexander J Howie; Vaksha Patel; Marie-Lucile Figueres; Horia C Stanescu; Naomi Issler; Jeremy K Nicholson; Detlef Bockenhauer; Christopher Laing; Stephen B Walsh; David A McCredie; Sue Povey; Audrey Asselin; Arnaud Picard; Aurore Coulomb; Alan J Medlar; Isabelle Bailleul-Forestier; Alain Verloes; Cedric Le Caignec; Gwenaelle Roussey; Julien Guiol; Bertrand Isidor; Clare Logan; Roger Shore; Colin Johnson; Christopher Inglehearn; Suhaila Al-Bahlani; Matthieu Schmittbuhl; François Clauss; Mathilde Huckert; Virginie Laugel; Emmanuelle Ginglinger; Sandra Pajarola; Giuseppina Spartà; Deborah Bartholdi; Anita Rauch; Marie-Claude Addor; Paulo M Yamaguti; Heloisa P Safatle; Ana Carolina Acevedo; Hercílio Martelli-Júnior; Pedro E dos Santos Netos; Ricardo D Coletta; Sandra Gruessel; Carolin Sandmann; Denise Ruehmann; Craig B Langman; Steven J Scheinman; Didem Ozdemir-Ozenen; Thomas C Hart; P Suzanne Hart; Ute Neugebauer; Eberhard Schlatter; Pascal Houillier; William A Gahl; Miikka Vikkula; Agnès Bloch-Zupan; Markus Bleich; Hiroshi Kitagawa; Robert J Unwin; Alan Mighell; Ariane Berdal; Robert Kleta
Journal:  Nephron Physiol       Date:  2013-02-23

8.  The effects of HAP and macrophage cells to the expression of inflammatory factors and apoptosis in HK-2 cells of vitro co-cultured system.

Authors:  Junchuan Yu; Yaoliang Deng; Zhiwei Tao; Weixia Liang; Xiaofeng Guan; Jihua Wu; Xin Ning; Yunlong Liu; Quan Liu; Ziqi He
Journal:  Urolithiasis       Date:  2017-12-13       Impact factor: 3.436

Review 9.  Metabolic syndrome and nephrolithiasis.

Authors:  Krishna Ramaswamy; Ojas Shah
Journal:  Transl Androl Urol       Date:  2014-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.